109451
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
基线扩展残疾状态量表评分和 CD8+ T 细胞水平是多发性硬化症致残进展的风险因素
Authors Liu PJ, Yuan P, Liu SP
Received 13 May 2025
Accepted for publication 1 October 2025
Published 29 October 2025 Volume 2025:18 Pages 15049—15061
DOI https://doi.org/10.2147/JIR.S540152
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Shouya Feng
Pen-Ju Liu, Peng Yuan, Shui-Ping Liu
Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People’s Republic of China
Correspondence: Pen-Ju Liu, Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing, 100029, People’s Republic of China, Tel +86 13521678687, Email lpjhq@163.com
Objective: This study aimed to investigate peripheral blood T cell subset characteristics and identify risk factors associated with disability progression in patients with multiple sclerosis (MS).
Methods: We retrospectively analysed the clinical data of patients with MS treated at the Neurology Department of our hospital between May 2014 and August 2024. T lymphocyte subsets were assessed using flow cytometry. Patients were categorised into disability progression and non-progression groups based on changes in their Expanded Disability Status Scale (EDSS) scores from baseline to final assessment. Clinical data from both groups were analysed to identify independent risk factors for disability progression.
Results: Of the patients with MS included, 68.84% had relapsing–remitting MS, with subacute onset being the most common (47.10%) and limb weakness the primary presenting symptom (34.06%). Significant differences (p < 0.05) were observed between progression and non-progression groups in disease duration, relapse frequency, onset symptoms, baseline and final EDSS scores and T lymphocyte subset distribution. Multivariate logistic regression analysis identified baseline EDSS score (95% confidence interval [CI]: 1.101– 2.253, p = 0.014) and CD8+ T cell levels (95% CI: 0.603– 1.491, p = 0.042) as independent risk factors for disability progression in patients with MS (p < 0.05).
Conclusion: Baseline EDSS scores and CD8+ T cell levels are independent risk factors for disability progression in MS and may serve as important indicators for monitoring disease progression.
Keywords: multiple sclerosis, T cell subsets, disability, risk factors
Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People’s Republic of China
Correspondence: Pen-Ju Liu, Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing, 100029, People’s Republic of China, Tel +86 13521678687, Email lpjhq@163.com
Objective: This study aimed to investigate peripheral blood T cell subset characteristics and identify risk factors associated with disability progression in patients with multiple sclerosis (MS).
Methods: We retrospectively analysed the clinical data of patients with MS treated at the Neurology Department of our hospital between May 2014 and August 2024. T lymphocyte subsets were assessed using flow cytometry. Patients were categorised into disability progression and non-progression groups based on changes in their Expanded Disability Status Scale (EDSS) scores from baseline to final assessment. Clinical data from both groups were analysed to identify independent risk factors for disability progression.
Results: Of the patients with MS included, 68.84% had relapsing–remitting MS, with subacute onset being the most common (47.10%) and limb weakness the primary presenting symptom (34.06%). Significant differences (p < 0.05) were observed between progression and non-progression groups in disease duration, relapse frequency, onset symptoms, baseline and final EDSS scores and T lymphocyte subset distribution. Multivariate logistic regression analysis identified baseline EDSS score (95% confidence interval [CI]: 1.101– 2.253, p = 0.014) and CD8+ T cell levels (95% CI: 0.603– 1.491, p = 0.042) as independent risk factors for disability progression in patients with MS (p < 0.05).
Conclusion: Baseline EDSS scores and CD8+ T cell levels are independent risk factors for disability progression in MS and may serve as important indicators for monitoring disease progression.
Keywords: multiple sclerosis, T cell subsets, disability, risk factors